Invention Grant
- Patent Title: Use of silver(I) complexes as anticancer agents
-
Application No.: US14363542Application Date: 2012-12-06
-
Publication No.: US09676801B2Publication Date: 2017-06-13
- Inventor: Reinout Meijboom , Marianne Jacqueline Cronje
- Applicant: University of Johannesburg
- Applicant Address: ZA
- Assignee: UNIVERSITY OF JOHANNESBURG
- Current Assignee: UNIVERSITY OF JOHANNESBURG
- Current Assignee Address: ZA
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: ZA11/08944 20111206
- International Application: PCT/IB2012/057029 WO 20121206
- International Announcement: WO2013/084185 WO 20130613
- Main IPC: A61K9/00
- IPC: A61K9/00 ; C07F9/54 ; A61K33/38 ; A61K31/66 ; A61K49/00
Abstract:
The present invention relates to the use of silver(I) monophosphine complexes as Active Pharmaceutical Ingredients (API's), including anticancer agents, for the treatment, diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer.
Public/Granted literature
- US20150037256A1 USE OF SILVER(I) COMPLEXES AS ANTICANCER AGENTS Public/Granted day:2015-02-05
Information query
